Fellowship · Madison, WI
Sponsored by University of Wisconsin Hospitals and Clinics
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML.
Blood advances · 2022 · 182 citations · Damodaran Narayanan
Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome.
JAAD case reports · 2022 · 50 citations · Damodaran Narayanan
Clinical Manifestations and Outcomes in Immunocompetent and Immunocompromised Patients With Blastomycosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021 · 43 citations · Eduard Matkovic
ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders.
The Journal of clinical investigation · 2025 · 15 citations · Erica Reinig
Splenic Abscess in the New Millennium: A Descriptive, Retrospective Case Series.
Open forum infectious diseases · 2022 · 26 citations · Savanah Gisriel
A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritis.
The Journal of experimental medicine · 2025 · 14 citations ·
Deletion of STAT3 from Foxd1 cell population protects mice from kidney fibrosis by inhibiting pericytes trans-differentiation and migration.
Cell reports · 2022 · 41 citations · Sujal Shah
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injury.
The Journal of clinical investigation · 2024 · 17 citations · Sujal Shah